Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

From The Quarterly Conference Calls

Aug 05 2002

• By The Pink Sheet

Related Content

Synthroid Sales Expected To Grow 12% For Year Following NDA Approval

Jul 29 2002

Bristol Inventory Issues Include High Supply Of Glucophage IR

May 06 2002

Augmentin Patent Appeal On Fast-Track; GSK Braces For Generics

May 27 2002

King Files 20 Levoxyl Patent Applications; Sales Up 65% to $27 Mil. In Q3

Nov 05 2001

Ligand Avinza Once-Daily Dosing Will Be Core Promo Message For Elan Opioid

Mar 25 2002

Elan Prialt NDA Awaits Longer-Term Data In Chronic Pain

Feb 11 2002

Medimmune FluMist Indication Could Exclude Patients With Asthma

Jul 15 2002

Schering PEG-Intron/Rebetol Wait List Patients To Receive Drug By April

Jan 28 2002

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window